Fruth Investment Management’s AstraZeneca AZN Stock Holding History

Fruth Investment Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$663K	Hold	3,499	–	–	0.16%	127
2026 Q1	$690K	Hold	3,499	–	–	0.17%	125
2025 Q4	$643K	Hold	3,499	–	–	0.17%	128
2025 Q3	$536K	Hold	3,499	–	–	0.15%	129
2025 Q2	$489K	Hold	3,499	–	–	0.13%	133
2025 Q1	$514K	Sell	3,499 -50	-1%	-$7.23K	0.14%	136
2024 Q4	$465K	Hold	3,549	–	–	0.13%	141
2024 Q3	$553K	Hold	3,549	–	–	0.14%	138
2024 Q2	$553K	Buy	3,549 +26	+0.7%	+$3.91K	0.15%	137
2024 Q1	$477K	Hold	3,523	–	–	0.12%	151
2023 Q4	$474K	Hold	3,523	–	–	0.13%	147
2023 Q3	$477K	Hold	3,523	–	–	0.14%	143
2023 Q2	$504K	Hold	3,523	–	–	0.14%	139
2023 Q1	$489K	Hold	3,523	–	–	0.14%	142
2022 Q4	$477K	Hold	3,523	–	–	0.14%	142
2022 Q3	$386K	Sell	3,523 -50	-1%	-$6.34K	0.13%	149
2022 Q2	$479K	Hold	3,573	–	–	0.13%	146
2022 Q1	$474K	Hold	3,573	–	–	0.13%	145
2021 Q4	$416K	Hold	3,573	–	–	0.11%	151
2021 Q3	$429K	Hold	3,573	–	–	0.13%	140
2021 Q2	$428K	Hold	3,573	–	–	0.13%	146
2021 Q1	$355K	Hold	3,573	–	–	0.11%	157
2020 Q4	$357K	Hold	3,573	–	–	0.12%	144
2020 Q3	$391K	Sell	3,573 -100	-3%	-$11.1K	0.16%	126
2020 Q2	$388K	Sell	3,673 -250	-6%	-$25.8K	0.16%	125
2020 Q1	$350K	Hold	3,923	–	–	0.18%	119
2019 Q4	$391K	Buy	3,923 +23	+0.6%	+$2.17K	0.15%	131
2019 Q3	$347K	Sell	3,900 -50	-1%	-$4.33K	0.14%	134
2019 Q2	$326K	Hold	3,950	–	–	0.13%	135
2019 Q1	$319K	Hold	3,950	–	–	0.13%	133
2018 Q4	$300K	Hold	3,950	–	–	0.14%	134
2018 Q3	$312K	Hold	3,950	–	–	0.13%	149
2018 Q2	$277K	Hold	3,950	–	–	0.12%	161
2018 Q1	$276K	Hold	3,950	–	–	0.12%	152
2017 Q4	$274K	Hold	3,950	–	–	0.12%	157
2017 Q3	$267K	Hold	3,950	–	–	0.12%	153
2017 Q2	$269K	Hold	3,950	–	–	0.13%	150
2017 Q1	$246K	Sell	3,950 -300	-7%	-$17.5K	0.11%	162
2016 Q4	$232K	Buy	4,250 +425	+11%	+$24.1K	0.11%	167
2016 Q3	$251K	Hold	3,825	–	–	0.12%	156
2016 Q2	$230K	Buy	3,825 +125	+3%	+$7.26K	0.11%	164
2016 Q1	$208K	Hold	3,700	–	–	0.1%	167
2015 Q4	$251K	Hold	3,700	–	–	0.13%	152
2015 Q3	$235K	Hold	3,700	–	–	0.12%	162
2015 Q2	$235K	Sell	3,700 -500	-12%	-$34.2K	0.11%	174
2015 Q1	$287K	Hold	4,200	–	–	0.12%	169
2014 Q4	$295K	Hold	4,200	–	–	0.12%	172
2014 Q3	$300K	Buy	4,200 +500	+14%	+$36.6K	0.13%	175
2014 Q2	$280K	Hold	3,700	–	–	0.13%	168
2014 Q1	$255K	Hold	3,700	–	–	0.12%	173
2013 Q4	$219K	Buy	+3,700	New	+$201K	0.1%	184

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fruth Investment Management's AZN Position: Q2 2026 in Review

Fruth Investment Management held its AstraZeneca (AZN) position steady in Q2 2026 at 3,499 shares worth $663K. The position accounts for 0.16% of the portfolio, ranked #127.

Fruth Investment Management first reported a position in AZN in Q4 2013 and has held it in 51 quarters since. The position peaked at $690K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Fruth Investment Management held 3,499 shares of AstraZeneca worth $663K as of Q2 2026.
Fruth Investment Management left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.16% of Fruth Investment Management's portfolio in Q2 2026, its #127 holding.
Fruth Investment Management first reported a position in AstraZeneca in Q4 2013 and has held it in 51 quarters since.
Fruth Investment Management's AstraZeneca position peaked at $690K in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Fruth Investment Management's 13F filing for Q2 2026, filed 10 Jul 2026.